List view / Grid view

# Preclinical Research

### Novel formulation could provide solution to cancer vaccine shortcomings

12 February 2020 | By

Researchers have developed a new formulation for cancer vaccines that could provide a solution to its delivery complications.

### Once-a-month oral contraceptive pill one step closer

5 December 2019 | By

A new slow-release formulation and delivery system for the oral contraceptive pill has shown success in pre-clinical trials and could be taken once a month.

### Priority Review granted to pemigatinib for treatment of cholangiocarcinoma

2 December 2019 | By

The US FDA has awarded pemigatinib Priority Review, after the drug met its primary and secondary endpoints in a Phase II trial.

### Whitepaper: The Use of Positron Emission Tomography (PET) in Pre-clinical Pharmaceutical Research

30 August 2019 | By

Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific metabolic functions.

### Novartis could face legal action over Zolgensma application

8 August 2019 | By

The pharmaceutical company failed to inform the FDA of manipulated data when the gene therapy was under review and could face a legal battle.

### Discoveries made through ‘routine’ research can now be patentable

28 March 2019 | By

In a ruling handed down on 27 March 2019 by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be rewarded with a patent...

### Advances in automated performance verification for UV/VIS spectrophotometers

22 August 2018 | By Mettler-Toledo

Regulated environments require performance verification (qualification) of UV/VIS spectrophotometers on a regular basis. Instrument performance is the main factor directly affecting the accuracy and repeatability of measurements. Hence, it is important that this is regularly monitored and that documentary evidence is provided. Optical performance verification is conducted to the widely…

### Whitepaper: Why should you care about Burkholderia cepacia?

17 August 2018 | By

The Burkholderia cepacia complex (BCC) species are a group of gram-negative, rod-shaped bacteria that have been shown in recent years to be of concern for patients, and thus for manufacturers of drugs and products that contribute to patient health...

### Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma

18 May 2018 | By

Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models.

### Robotic method isolates high-producing cell lines for HIV vaccine production

6 February 2018 | By

Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...

### Scientists identify bacterial link with oesophageal cancer

1 December 2017 | By

Researchers at NYU Langone Health's Perlmutter Cancer Center report that at least three kinds of bacteria in the mouths of Americans may directly affect their risk of developing oesophageal cancer.

### Drugs taken before surgery may reduce metastatic recurrence

7 August 2017 | By

Researchers have identified a drug regimen administered prior to and after surgery that significantly reduces the risk of post-surgical cancer recurrence...

### Collaboration is ‘game changer’ in delivering cell and gene therapies

19 June 2017 | By

Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss.

### Ensuring patient safety during clinical trials; translation to preclinical drug discovery

3 September 2012 | By David Cook & James Milligan, AstraZeneca

Ensuring patient safety during clinical trials is of paramount consideration with stringent monitoring built into trials (and beyond) and the design and interpretation of safety outcomes subject to a large amount of regulation. As a result, it is rare for clinical trials to produce extreme adverse drug reactions but it…